Wireless lung sensor could keep heart failure patients out of hospital
NCT ID NCT03375710
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a device called the Cordella™ Heart Failure System in 15 people with advanced heart failure. The system includes a small sensor implanted in the lung artery that measures pressure, sending data to doctors remotely. The goal was to see if it is safe and accurate, potentially allowing earlier treatment adjustments and fewer hospital visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cordella™ Heart Failure System (a home monitoring device with a pulmonary artery pressure sensor implant)
What this could lead to
If successful, this system could help doctors manage heart failure remotely, potentially reducing hospital stays and improving quality of life for patients.
What could go wrong
This was a small, early feasibility study with only 15 participants, so results may not apply to all patients. The device requires an implant, which carries risks like infection or sensor failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Galway University Hospital
Galway, H91 YR71, Ireland
-
Ziekenhuis Oost Limburg
Genk, 3600, Belgium